Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02TYC
|
|||
Former ID |
DNC000309
|
|||
Drug Name |
BetaARKct
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Beta-adrenergic receptor kinase 1 (ADRBK1) | Target Info | Inhibitor | [1] |
KEGG Pathway | Chemokine signaling pathway | |||
Endocytosis | ||||
Glutamatergic synapse | ||||
Morphine addiction | ||||
Panther Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | ||||
Parkinson disease | ||||
Angiotensin II-stimulated signaling through G proteins and beta-arrestin | ||||
Pathway Interaction Database | Signaling events mediated by HDAC Class II | |||
Thromboxane A2 receptor signaling | ||||
CXCR4-mediated signaling events | ||||
Signaling events mediated by the Hedgehog family | ||||
IL8- and CXCR1-mediated signaling events | ||||
Reactome | Calmodulin induced events | |||
G alpha (q) signalling events | ||||
Activation of SMO | ||||
WikiPathways | Hedgehog Signaling Pathway | |||
DAG and IP3 signaling | ||||
Gastrin-CREB signalling pathway via PKC and MAPK | ||||
Opioid Signalling | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Gene-mediated inhibition of the b-adrenergic receptor kinase: a new therapeutic strategy for heart failure. Minerva Cardioangiol. 2001 Dec;49(6):389-94. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.